Obesity and inactivity are associated with endothelial dysfunction that may contribute to the development of atherosclerosis. We examined the effects of a short-term lifestyle intervention on circulating biomarkers of endothelial health. Nineteen overweight or obese (mean body mass index (BMI): 28.9 +/- 0.7 kg/m2) men and women underwent 6 weeks of body mass reduction induced by moderate energy restriction (approximately 750 kcal/d; 1 kcal = 4.184 kJ) and aerobic training (approximately 400 kcal/d). Fasting serum samples were collected at baseline and after reduction in body mass (week 6) to assess concentrations of nitrotyrosine (NT), secretory phospholipase A2 (sPLA2), and soluble intracellular adhesion molecule-1 (sICAM-1). Body mass was significantly reduced from 81.3 +/- 2.8 to 77.3 +/- 2.6 kg (p < 0.05). Circulating concentrations of NT and sICAM-1 were significantly reduced with treatment (approximately 25% and approximately 10%, respectively), whereas sPLA2 levels were significantly elevated (approximately 45%). Elevations in sPLA2 were negatively correlated with changes in NT (r = -0.58, p = 0.047); reductions in NT did not correlate significantly with reductions in sICAM-1. It appears that circulating markers of endothelial health are susceptible to short-term exercise interventions with modest reduction in body mass, and such a lifestyle modification may improve endothelial health by reducing protein nitration products and cellular adhesion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1139/h06-040 | DOI Listing |
Viruses
December 2024
1st Internal Medicine Department, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, 55436 Thessaloniki, Greece.
People with HIV (PWH) have an elevated risk of cardiovascular disease compared to those without HIV. This study aimed to investigate the relative serum expression of microRNAs (miRNAs) associated with arterial stiffness, a significant marker of cardiovascular disease. A total of 36 male PWH and 36 people without HIV, matched for age, body mass index, pack years, and dyslipidemia, were included in the study.
View Article and Find Full Text PDFVaccines (Basel)
November 2024
Women's and Children's Health Network, North Adelaide, SA 5006, Australia.
Background/objectives: Influenza vaccination is recommended for pregnant women, offering the dual benefit of protecting pregnant women and their newborn infants against influenza. This study aimed to investigate the impact of body mass index (BMI) on influenza vaccine responses in pregnant women and their newborns.
Methods: Participants included pregnant women attending the Women's and Children's Hospital in South Australia between 2018 and 2021.
Sensors (Basel)
December 2024
National Institute of Physical Education of Catalonia (INEFC), 08038 Barcelona, Spain.
Several microtechnology devices quantify the external load of team sports using Global Positioning Systems sampling at 5, 10, or 15 Hz. However, for short, explosive actions, such as collisions, these sample rates may be limiting. It is known that very high-frequency sampling is capable of capturing changes in actions over a short period of time.
View Article and Find Full Text PDFSensors (Basel)
December 2024
Applied Biomechanics and Sport Technology Research Group, Autonomous University of Madrid, 28049 Madrid, Spain.
The countermovement jump (CMJ) is a widely used test to assess lower body neuromuscular performance. This study aims to analyze the validity and reliability of an iOS application using artificial intelligence to measure CMJ height, force, velocity, and power in unloaded and loaded conditions. Twelve physically active participants performed 12 CMJs with external loads ranging from 0% to 70% of their body mass while being simultaneously monitored with a pair of force platforms and the My Jump Lab application.
View Article and Find Full Text PDFPharmaceutics
November 2024
Department of Pharmacy Practice, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.
Gabapentin has variable pharmacokinetics (PK), which contributes to difficulty in dosing and increased risk of adverse events. The objective of this study was to leverage gabapentin concentrations from therapeutic drug monitoring (TDM) to develop a population PK (popPK) model and characterize significant covariates that impact gabapentin PK. Data were retrospectively collected from 82 hospitalized adult patients with TDM gabapentin concentrations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!